2013-07-11 18:09:59 - New Pharmaceuticals market report from GlobalData: "EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2022"
Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004). Due to its chronic and relapsing nature, atopic dermatitis presents a global public health concern, with reported lifetime prevalence ranging between 10%-20% in children and 1%-3% in adults (Larsen and Hanifin, 2002). In general, the prevalence of atopic dermatitis is increasing worldwide, with high prevalence in western and developed nations compared with other parts of the world. However, recent trends demonstrate a gradual rise in prevalence in developing countries and plateauing prevalence in developed countries (Asher et al., 2006). Although atopic dermatitis
is not life-threatening, it has a huge impact on economic burden and quality of life of individuals (Carroll et al., 2005).
GlobalData's epidemiological analysis forecasts that prevalent cases of atopic dermatitis in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India) will increase from 132.28 million in 2012 to 132.71 million cases in 2022 at an annual growth rate (AGR) of 0.10%. In 2012, China and India combined contributed 83.04 million cases, comprising more than 60% of the total prevalent cases in the 9MM.
Full Report Details at
- www.fastmr.com/prod/642946_epicast_report_atopic_dermatitis_epid ..
GlobalData's epidemiological forecast projects a substantial increase in the lifetime prevalent cases of atopic dermatitis in the 9MM over the forecast period (2012-2022). As GlobalData epidemiologists used steady prevalence proportions of atopic dermatitis over the forecast period, the growth in prevalent cases in each market can be attributed to the change in population demographics in the respective markets, especially in the younger age groups as they comprise the highest proportion of the prevalent cases. The forecast underscores the considerable psychosocial and economic burden inflicted by atopic dermatitis particularly among children. Governments in the respective markets should develop strategies to tackle the growing problem and direct appropriate interventions towards reducing various triggers inducing atopic dermatitis especially among young children (Williams et al., 2012).
* The Atopic Dermatitis EpiCast Report provides an overview of the risk factors and global trends of atopic dermatitis in the 9MM.
* It includes a 10-year epidemiology forecast of atopic dermatitis prevalent cases segmented by age (in five-year increments beginning at age 0 and ending at ages 85 years and older), sex, and severity (mild, moderate, and severe) in the 9MM.
Reasons to Get this Report
* Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market.
* Quantify patient populations in the global atopic dermatitis market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for atopic dermatitis therapeutics in each of the markets covered.
* Identify the percentage of atopic dermatitis prevalent cases that are mild, moderate, and severe.
Partial Table of Contents:
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.2 Related Reports
2.3 Upcoming Reports
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.2.1 Children ages ≤ 10 years are three times more likely to develop atopic dermatitis
3.2.2 Family history of atopic disease increases the risk of atopic dermatitis six-fold
3.2.3 Allergens are associated with a six-fold risk of atopic dermatitis
3.2.4 Breastfeeding for more than four months protects children from atopic dermatitis
3.2.5 Asthma, allergic rhinitis and allergic conjunctivitis commonly occur with atopic dermatitis
3.2.6 Atopic dermatitis patients are up to three times more likely to have psychiatric disorders
3.3 Global Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Sources Not Used
3.5 Forecast Assumptions and Methods
3.6 Epidemiology Forecast of Atopic Dermatitis (2001-2022)
3.6.1 Lifetime Prevalent Cases of Atopic Dermatitis
3.6.2 Age-Specific Prevalent Cases of Lifetime Atopic Dermatitis
3.6.3 Sex-Specific Prevalent Cases of Lifetime Atopic Dermatitis
3.6.4 Age-Standardized Lifetime Prevalence of Atopic Dermatitis
3.6.5 Prevalent Cases of Atopic Dermatitis by Severity
3.7.1 Conclusions on Epidemiological Trends
3.7.2 Limitations of the Analysis
3.7.3 Strengths of the Analysis
4.2 About the Authors
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
List of Tables
1.1 List of Tables
Table 1: Atopic Dermatitis, Risk Factors and Comorbidities
Table 2: Diagnostic Criteria for Atopic Dermatitis
Table 3: The Hanifin and Rajka Diagnostic Criteria for Atopic Dermatitis
Table 4: All Markets, Epidemiological Sources for Lifetime Atopic Dermatitis Prevalence
Table 5: All Markets, Epidemiological Sources of Atopic Dermatitis Severity Data
Full Table of Contents is available at:
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.